Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Collegium Pharmaceutical (COLL) Interest & Investment Income: 2016-2025

Historic Interest & Investment Income for Collegium Pharmaceutical (COLL) over the last 9 years, with Sep 2025 value amounting to $3.1 million.

  • Collegium Pharmaceutical's Interest & Investment Income fell 5.00% to $3.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.5 million, marking a year-over-year decrease of 42.09%. This contributed to the annual value of $14.0 million for FY2024, which is 10.50% down from last year.
  • As of Q3 2025, Collegium Pharmaceutical's Interest & Investment Income stood at $3.1 million, which was up 30.76% from $2.4 million recorded in Q2 2025.
  • In the past 5 years, Collegium Pharmaceutical's Interest & Investment Income ranged from a high of $4.5 million in Q3 2023 and a low of $3,000 during Q1 2021.
  • For the 3-year period, Collegium Pharmaceutical's Interest & Investment Income averaged around $3.4 million, with its median value being $3.3 million (2024).
  • As far as peak fluctuations go, Collegium Pharmaceutical's Interest & Investment Income tumbled by 98.58% in 2021, and later surged by 80,440.00% in 2023.
  • Collegium Pharmaceutical's Interest & Investment Income (Quarterly) stood at $3,000 in 2021, then soared by 34,133.33% to $1.0 million in 2022, then surged by 318.99% to $4.3 million in 2023, then plummeted by 57.89% to $1.8 million in 2024, then dropped by 5.00% to $3.1 million in 2025.
  • Its Interest & Investment Income was $3.1 million in Q3 2025, compared to $2.4 million in Q2 2025 and $2.2 million in Q1 2025.